Open-to-Accrual Therapeutic Trials


Dr Ted Johnson in lab
Help us say Yes. It's time.

Protocol ID

Official Title

PI Name

Contact Person

Disease Site

Phase

 NLG-2105 
ClinicalTrials.gov: 
NCT02502708
 Phase 1 Trial
of Indoximod
in Combination
with Temozolomide-based Therapy for Children with Progressive
Primary Brain
Tumors
 T. Johnson Robin Dobbins
& 
Kimberly Gray
 Brain Tumor  I
NMTRC014 
ClinicalTrials.gov: 
NCT02679144
NMTT -
Neuroblastoma Maintenance
Therapy Trial
Using Difluoromethylornithine (DFMO);
NMTRC014
 
 C. McDonough Kimberly Gray  Neuroblastoma  II

AHOD1331     ClinicalTrials.gov:  NCT02166463

A Randomized Phase III Study of Brentuximab Vedotin (SGN-35, IND #117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents Protocol C. McDonough Robin Dobbins
& 
Kimberly Gray
Classical Hodgkin Lymphoma III
 
 

Contact Us

Georgia Cancer Center Pediatric Immunotherapy
Augusta University
Health Science Campus
Georgia Cancer Research Center

Robin Dobbins, RN
Senior Clinical Research Nurse
Office: 706-721-2154

Beth Fisher, RN, PNP
Immunotherapy Nurse-Practitioner
Office: 706-723-0000

Kimberly Gray
Research Manager
Office: 706-721-1870

Theodore S. Johnson, M.D., Ph.D.
Director, Clinical Pediatric Immunotherapy Service
Georgia Cancer Center
Office: 706-721-4962
Fax:     (706) 721-4804